Ayr Wellness (OTCMKTS:AYRWF – Get Rating) and ChromaDex (NASDAQ:CDXC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership.

Profitability

This table compares Ayr Wellness and ChromaDex's net margins, return on equity and return on assets.

Institutional & Insider Ownership

0.3% of Ayr Wellness shares are owned by institutional investors. Comparatively, 41.8% of ChromaDex shares are owned by institutional investors. 11.8% of ChromaDex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

Ayr Wellness presently has a consensus price target of $22.13, indicating a potential upside of 496.01%. ChromaDex has a consensus price target of $5.48, indicating a potential upside of 277.59%. Given Ayr Wellness' stronger consensus rating and higher possible upside, research analysts clearly believe Ayr Wellness is more favorable than ChromaDex.

Valuation & Earnings

This table compares Ayr Wellness and ChromaDex's top-line revenue, earnings per share (EPS) and valuation.

Ayr Wellness has higher revenue and earnings than ChromaDex. Ayr Wellness is trading at a lower price-to-earnings ratio than ChromaDex, indicating that it is currently the more affordable of the two stocks.

Summary

Ayr Wellness beats ChromaDex on 9 of the 13 factors compared between the two stocks.

About Ayr Wellness

(Get Rating)

Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizers. It also provides administrative, consulting, and operations support services to licensed cannabis companies. As of August 11, 2022, Ayr Wellness Inc. operated 50 dispensaries. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

About ChromaDex

(Get Rating)

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.